Elanco Animal Health Inc. ELAN Contract Manufacturing — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Elanco Animal Health Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Elanco Animal Health Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Elanco Animal Health Inc.'s contract manufacturing — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Elanco Animal Health Inc.'s contract manufacturing — revenue?
- Elanco Animal Health Inc. (ELAN) reported contract manufacturing — revenue of $19M in Q1 2026.
- How has Elanco Animal Health Inc.'s contract manufacturing — revenue changed year-over-year?
- Elanco Animal Health Inc.'s contract manufacturing — revenue increased by 58.3% year-over-year, from $12M to $19M.
- What is the long-term trend for Elanco Animal Health Inc.'s contract manufacturing — revenue?
- Over 4 years (2021 to 2025), Elanco Animal Health Inc.'s contract manufacturing — revenue has grown at a -10.3% compound annual growth rate (CAGR), from $82M to $53M.
- What does contract manufacturing — revenue mean?
- Revenue earned by manufacturing products for other companies using internal production facilities.
- How do you interpret contract manufacturing — revenue?
- An increase suggests higher utilization of manufacturing assets or expanded partnerships with third-party clients, while a decrease may indicate a strategic shift away from contract services or reduced demand from external partners.
- How does contract manufacturing — revenue compare across companies?
- Peers in the pharmaceutical or animal health space often report this as 'Contract Manufacturing' or 'Third-Party Manufacturing' revenue, which is typically viewed as a non-core, lower-margin activity compared to proprietary product sales.